Pharmaceutical and biotechnology firms' pandemic foreign policies.
This article addresses some practical questions about the international behaviour of pharmaceutical and biotechnology firms making vaccines against COVID-19 and, by doing so, seeks to operationalize the idea that these firms had distinct foreign policies. Building on the existing literature on non-s...
| Publicado en: | International Affairs Vol. 101; no. 5; pp. 1877 - 1898 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Oxford University Press / USA
Sep2025
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=188027987&site=ehost-live header: @attributes: shortDbName: ssf uiTerm: 188027987 longDbName: Social Sciences Full Text (H.W. Wilson) uiTag: AN controlInfo: bkinfo: jinfo: jid: 00205850 INA jtl: International Affairs issn: 00205850 maglogo: N pubinfo: dt: Sep2025 vid: 101 iid: 5 pid: 622 pub: Oxford University Press / USA artinfo: ui: 188027987 10.1093/ia/iiaf067 ppf: 1877 ppct: 21 formats: fmt: – @attributes: type: T db: hlh ui: 188027987 – @attributes: type: P db: hlh ui: 188027987 tig: atl: Pharmaceutical and biotechnology firms' pandemic foreign policies. aug: au: Spear, Joanna su: COVID-19 pandemic Pharmaceutical biotechnology Pharmaceutical policy Non-state actors (International relations) Purchasing contracts sug: subj: COVID-19 pandemic Research and Development in Biotechnology Pharmaceutical and medicine manufacturing Pharmaceuticals and pharmacy supplies merchant wholesalers Drugs and Druggists' Sundries Merchant Wholesalers Pharmaceutical biotechnology Pharmaceutical policy Non-state actors (International relations) Purchasing contracts keyword: biotechnology firms foreign pandemic pharmaceutical policies biotechnology firms foreign pandemic pharmaceutical policies ab: This article addresses some practical questions about the international behaviour of pharmaceutical and biotechnology firms making vaccines against COVID-19 and, by doing so, seeks to operationalize the idea that these firms had distinct foreign policies. Building on the existing literature on non-state actors as foreign policy actors, this article asks how firms formulated and implemented their foreign policies during the COVID-19 pandemic. At two specific points during the pandemic, pharmaceutical and biotechnology firms had strong hands to play in their negotiations with multiple states. First, when governments were scrambling to secure advanced purchase agreements for vaccine doses early in the pandemic and were willing to make major concessions to the firms; and second, when the firms' vaccine candidates had been authorized for use and multiple governments wanted their deliveries as quickly as possible, with firms controlling when governments received their orders. Following Christopher Hill's work, the firms are found to have undertaken five sets of activities that, taken together, amount to them having foreign policies: setting objectives and goals; deciding their pandemic strategies; establishing timelines for the achievement of each goal; deciding on instruments; and implementing their strategies to achieve their objectives. The vaccine firms had distinct strategies and notably gave profits different degrees of importance in their pandemic foreign policies. pubtype: Academic Journal doctype: Article src: R language: English refInfo: copyright: @attributes: flag: N holdings: @attributes: islocal: N |
|---|